A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis
© 2023 Zhou et al..
Introduction: Psoriasis is an immune-mediated chronic inflammatory skin disease. As our understanding of the pathogenesis of psoriasis has improved, biologic agents have become increasingly important in the treatment of psoriasis. However, the use of biologic agents is associated with cutaneous side effects. A new type of side effect called paradoxical reactions is an emerging threat arising from the increasing use of biologic agents.
Case: Here, we present a case of paradoxical skin reactions - pyoderma gangrenosum (PG) and eczema - induced by biologic therapy. The case was successfully and eventually treated with baricitinib.
Discussion: PG is a rare inflammatory disease characterised by painful and necrotic ulcerations containing neutrophils. It has been associated with autoimmune diseases such as inflammatory bowel disease (IBD). TNF (tumor necrosis factor) -α inhibitors can effectively treat refractory PG, while IL (interleukin) -17A inhibitors may worsen IBD symptoms. The cause of PG in this case was believed to be secukinumab, not adalimumab. The patient was diagnosed with eczematous dermatitis due to TNF-α inhibitors, and baricitinib was added to treat eczematous dermatitis.
Conclusion: Paradoxical reactions are unpredictable events that may occur during treatment with biologics at anytime. They need further research in order to formulate personalised treatment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Clinical, cosmetic and investigational dermatology - 16(2023) vom: 14., Seite 1493-1497 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhou, Qianqian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adalimumab |
|---|
| Anmerkungen: |
Date Revised 20.06.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.2147/CCID.S412520 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358350670 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358350670 | ||
| 003 | DE-627 | ||
| 005 | 20231226074544.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2147/CCID.S412520 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1194.xml |
| 035 | |a (DE-627)NLM358350670 | ||
| 035 | |a (NLM)37333515 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhou, Qianqian |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.06.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 Zhou et al. | ||
| 520 | |a Introduction: Psoriasis is an immune-mediated chronic inflammatory skin disease. As our understanding of the pathogenesis of psoriasis has improved, biologic agents have become increasingly important in the treatment of psoriasis. However, the use of biologic agents is associated with cutaneous side effects. A new type of side effect called paradoxical reactions is an emerging threat arising from the increasing use of biologic agents | ||
| 520 | |a Case: Here, we present a case of paradoxical skin reactions - pyoderma gangrenosum (PG) and eczema - induced by biologic therapy. The case was successfully and eventually treated with baricitinib | ||
| 520 | |a Discussion: PG is a rare inflammatory disease characterised by painful and necrotic ulcerations containing neutrophils. It has been associated with autoimmune diseases such as inflammatory bowel disease (IBD). TNF (tumor necrosis factor) -α inhibitors can effectively treat refractory PG, while IL (interleukin) -17A inhibitors may worsen IBD symptoms. The cause of PG in this case was believed to be secukinumab, not adalimumab. The patient was diagnosed with eczematous dermatitis due to TNF-α inhibitors, and baricitinib was added to treat eczematous dermatitis | ||
| 520 | |a Conclusion: Paradoxical reactions are unpredictable events that may occur during treatment with biologics at anytime. They need further research in order to formulate personalised treatment | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a adalimumab | |
| 650 | 4 | |a baricitinib | |
| 650 | 4 | |a biology drugs | |
| 650 | 4 | |a eczema | |
| 650 | 4 | |a pyoderma gangrenosum | |
| 650 | 4 | |a secukinumab | |
| 700 | 1 | |a Zhou, Shengru |e verfasserin |4 aut | |
| 700 | 1 | |a Xiong, Huizi |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Jianqiu |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Ziliang |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Naihui |e verfasserin |4 aut | |
| 700 | 1 | |a Mao, Jinzhu |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Min |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical, cosmetic and investigational dermatology |d 2008 |g 16(2023) vom: 14., Seite 1493-1497 |w (DE-627)NLM206946538 |x 1178-7015 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2023 |g day:14 |g pages:1493-1497 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2147/CCID.S412520 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2023 |b 14 |h 1493-1497 | ||